Blood And Tissue Screening Tests Top Australia’s IVD Regulatory Scheme
This article was originally published in The Gray Sheet
Executive Summary
In vitro diagnostics that screen for pathogens in the blood supply or in organ and tissue donations would be regulated as highest-risk Class IV devices under the regulatory framework for IVDs proposed by Australia's Therapeutic Goods Administration (TGA)
You may also be interested in...
Australian IVD Framework Proposal Would Broaden Regulatory Oversight
Australia's proposed regulatory structure for in vitro diagnostic devices would bring new regulatory requirements and costs for a number of products that currently are exempt from oversight
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.